In Brief: Glaxo Wellcome Epivir
Executive Summary
Glaxo Wellcome Epivir: Lamivudine gains April 11 traditional approval in reducing the risk of death and disease progression in people with AIDS. The product has been approved for use in combination with the company's Retrovir (zidovudine; AZT). Epivir received accelerated approval in November 1995...